Return to program book search
Congenital Melanocytic Nevi: What's New?
Tuesday, March 25
7:15 AM - 8:45 AM
Daniel Brian Eisen, MD, FAAD
Following this course, the attendee should be able to:
- Assess the risks associated with a giant congenital melanocytic nevus
- Outline potential strategies for evaluating a patient with a congenital melanocytic nevus
- List newly described treatment methods for congenital melanocytic nevi
This session will cover what's new in our understanding of the risks associated with congenital melanocytic nevi, potential strategies to manage newly diagnosed patients, and available treatments. Risk factors for neurocutaneous melanosis and melanoma will be explored. Participants will learn about the bimodal distribution of congenital melanocytic associated melanomas. The benefits and risks of imaging young children to screen for neurocutaneous melanosis will be discussed. Participants will also learn about the current debate regarding the need for prophylactic excision as well as controversies regarding other potential treatments such as laser therapy. The latest literature on these topics will be incorporated.